(Q36365668)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16406224%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

Safety and immunogenicity of a combined DTPa-IPV vaccine administered as a booster from 4 years of age: a review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16406224%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16406224%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Stephen B. Lambert

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16406224%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Peter Richmond

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16406224%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Helen Marshall

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16406224%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

Jacquet JM

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16406224%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Bégué P

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16406224%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Grimprel E

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16406224%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Reinert P

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16406224%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Sandbu S

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16406224%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Faldella G

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16406224%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Nolan T

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16406224%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Roberton D

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16406224%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Schuerman L

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16406224%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

language of work or name

English

0 references

publication date

20 December 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16406224%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16406224%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16406224%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16406224%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

2440-2448

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16406224%20AND%20SRC:MED&resulttype=core&format=json

Pertussis immunisation in Europe - the situation in late 1999

15 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.009

Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.009

Pertussis of adults and infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.009

Influence of vaccination coverage on pertussis transmission in France

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.009

Severe and unrecognised: pertussis in UK infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.009

Pediatric deaths due to community-acquired bacterial infection. Survey of French pediatric intensive care units

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.009

Immunogenicity of a three-component acellular pertussis vaccine administered at birth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.009

New Pertussis Vaccination Strategies beyond Infancy: Recommendations by the Global Pertussis Initiative

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.009

Reactogenicity and immunogenicity of a booster dose of a combined diphtheria, tetanus, and tricomponent acellular pertussis vaccine at fourteen to twenty-eight months of age

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.009

Safety and immunogenicity of six acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fifth dose in four- to six-year-old children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.009

Extensive swelling after booster doses of acellular pertussis-tetanus-diphtheria vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.009

Reactogenicity and immunogenicity at preschool age of a booster dose of two three-component diphtheria-tetanus-acellular pertussis vaccines in children primed in infancy with acellular vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.009

Comparison of a three-component acellular pertussis vaccine with a whole-cell pertussis vaccine in 4- through 6-year-old children. Elmwood Pediatric Associates, Pennridge Pediatric Associates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.009

A comparison of enzyme-linked immunosorbent assay (ELISA) with the toxin neutralization test in mice as a method for the estimation of tetanus antitoxin in human sera

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.009

Estimation of Corynebacterium diphtheriae antitoxin in human sera: A comparison of an enzyme-linked immunosorbent assay with the toxin neutralisation test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.009

Micro cell culture method for determination of diphtheria toxin and antitoxin titres using VERO cells. I. Studies on factors affecting the toxin and antitoxin titration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.009

Micro cell culture method for determination of diphtheria toxin and antitoxin titres using VERO cells. II. Comparison with the rabbit skin method and practical application for seroepidemiological studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.009

A fourth dose of DTPa-IPV vaccine given to 4-6 year old children in Italy and Sweden following primary vaccination at 3, 5 and 11-12 months of age

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.009

Comparative reactogenicity and immunogenicity of booster doses of diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine and diphtheria-tetanus-inactivated poliovirus vaccine in preadolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.009

A comparison of booster immunisation with a combination DTPa-IPV vaccine or DTPa plus IPV in separate injections when co-administered with MMR, at age 4–6 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.009

Cell‐Mediated Immunity and Antibody Responses toBordetella pertussisAntigens in Children with a History of Pertussis Infection and in Recipients of an Acellular Pertussis Vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.009

Reduced-antigen combined diphtheria-tetanus-acellular pertussis vaccine (Boostrix).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.009

Anti-diphtheria antibody seroprotection rates are similar 10 years after vaccination with dTpa or DTPa using a mathematical model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.009

Comparison of a fifth dose of a five-component acellular or a whole cell pertussis vaccine in children four to six years of age

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.009

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.009

inferred from DOI database lookup

7 January 2021

based on heuristic

Nature, evolution, and appraisal of adverse events and antibody response associated with the fifth consecutive dose of a five-component acellular pertussis-based combination vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.009

Assessment of injection site reactions to an acellular pertussis-based combination vaccine, including novel use of skin tests with vaccine antigens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.009

Injection-Site Reactions to Booster Doses of Acellular Pertussis Vaccine: Rate, Severity, and Anticipated Impact

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.009

Extensive limb swelling after immunization: reports to the Vaccine Adverse Event Reporting System

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.009

Extensive swelling reactions occurring after booster doses of diphtheria-tetanus-acellular pertussis vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.009

Booster immunization of children with an acellular pertussis vaccine enhances Th2 cytokine production and serum IgE responses against pertussis toxin but not against common allergens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.009

Adverse reactions and antibody response to four doses of acellular or whole cell pertussis vaccine combined with diphtheria and tetanus toxoids in the first 19 months of life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.009

Reduced-antigen-content-diphtheria-tetanus-acellular-pertussis and inactivated polio vaccine as a booster for adolescents 10 to 14 years of age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.009

Immunogenicity and safety of a low-dose diphtheria, tetanus and acellular pertussis combination vaccine with either inactivated or oral polio vaccine as a pre-school booster in UK children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.009

10.1016/J.VACCINE.2005.12.009

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16406224%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference